Search

Your search keyword '"Yao, Zhan"' showing total 569 results

Search Constraints

Start Over You searched for: Author "Yao, Zhan" Remove constraint Author: "Yao, Zhan"
569 results on '"Yao, Zhan"'

Search Results

1. Highly stable modular-assembled laser system for a dual-atom-interferometer gyroscope

2. Compact multi-channel radio frequency pulse sequence generator with fast switching capability for cold atom interferometers

3. Self-Calibrated Atom-Interferometer Gyroscope by Modulating Atomic Velocities

4. Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma

5. Self-Alignment of a Large-Area Dual-Atom-Interferometer Gyroscope Using Parameter Decoupled Phase Seeking Calibrations

7. ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1

8. ZAIGA: Zhaoshan Long-baseline Atom Interferometer Gravitation Antenna

9. Competition effects of multiple quantum paths in an atom interferometer

12. Calibration of atomic trajectories in a large-area dual-atom-interferometer gyroscope

14. Effect of sintering time on microstructure and properties of extra-coarse-grained WC-10Co cemented carbide

15. Coadministration of Compound Danshen dripping pills and bezafibrate has a protective effect against diabetic retinopathy

17. Characterization of a Novel LUCAT1/miR-4316/VEGF-A Axis in Metastasis and Glycolysis of Lung Adenocarcinoma

20. Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence

21. Occurrence Frequency of Global Atmospheric River (AR) Events: A Data Fusion Analysis of 12 Identification Data Sets.

23. Compact multi-channel radio frequency pulse-sequence generator with fast-switching capability for cold-atom interferometers

25. The risk of death within 5 years of first hospital admission in older adults

28. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer

29. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer

31. Data from Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

32. Data from V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer

33. Supplementary Figure S1 from Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS–ERK Signaling

34. Data from A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAFV600E-Mutant Brain Tumor

35. Supplementary Data from V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer

36. Data from Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS–ERK Signaling

37. Figure S1-S5 from Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties

38. Data from Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties

39. Supplementary Figure Legends from Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS–ERK Signaling

40. Supplementary Material from A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAFV600E-Mutant Brain Tumor

41. Supplementary Methods, Figures 1 - 5, Tables 1 - 5 from Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

42. Table S1 from Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties

43. Supplementary Materials and Methods from Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS–ERK Signaling

46. Supplementary Figure Legends from Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition

47. Data from Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition

48. Supplementary Data from Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer

50. Supplementary Data from Response to Anti-EGFR Therapy in Patients with BRAF non-V600–Mutant Metastatic Colorectal Cancer

Catalog

Books, media, physical & digital resources